微创主动脉瓣置换联合经皮脑保护系统:经导管技术向外科手术的转化
本文报告一例71岁低危重度主动脉瓣狭窄患者,升主动脉严重钙化。手术团队将微创外科主动脉瓣置换与TAVI中常用的经皮脑保护系统联合应用,手术成功。作者认为心脏外科医生可采纳经导管技术以改善手术结果。
要点
- 低危重度主动脉瓣狭窄合并升主动脉严重钙化者,可考虑微创外科换瓣联合经皮脑保护系统。
- 经皮脑保护系统原用于TAVI,可转化应用于外科主动脉瓣置换以改善术中结果。
- TAVI在低危年轻患者中因瓣膜耐久性数据缺乏而受限,外科换瓣仍是可选方案。
核心结论
- 微创外科主动脉瓣置换联合经皮脑保护系统在升主动脉严重钙化的低危患者中可成功实施。
- 心脏外科医生可采纳经导管技术以改善手术结果。
研究设计与样本
- 病例报告:一例71岁低危重度主动脉瓣狭窄伴升主动脉严重钙化患者。
- 干预:微创外科主动脉瓣置换联合经皮脑保护系统(该装置常用于TAVI)。
主要发现
- 该低危71岁患者升主动脉严重钙化,微创外科换瓣联合经皮脑保护系统手术成功。
- TAVI在高危和中危患者中有价值,在瓷化或严重钙化主动脉者常优先于外科换瓣。
- TAVI瓣膜耐久性数据缺乏,使其在年轻低危患者中的应用存在顾虑。
临床怎么用
- 对升主动脉严重钙化的低危重度主动脉瓣狭窄患者,可考虑微创外科换瓣联合经皮脑保护系统。
- 心脏外科可借鉴TAVI的经导管技术(如脑保护装置)以改善手术结果。
局限性
- 本文为单例病例报告,未提供样本量、随访或对照数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients with severe aortic valve stenosis are currently treated with 2 different interventional techniques: surgical aortic valve replacement or transcatheter aortic valve implantation (TAVI). Both have strengths and limitations. On the one hand, TAVI represents a valuable option in high- and intermediate-risk patients and is commonly preferred over surgical aortic valve replacement in subjects with porcelain or severely calcified aorta, on the other, the lack of data on valve durability raises concerns on its use in young, low-risk patients. We present herein the case of a low-risk 71-year-old patient with a severely calcified ascending aorta. We successfully combined our minimally invasive surgical approach with the use of a percutaneous cerebral protection system commonly employed during TAVI procedures. We believe that cardiac surgeons could adopt transcatheter technology to improve operative results.
引用
- Di Eusanio M, Cefarelli M, Berretta P, et al. Minimally invasive aortic valve replacement with a catheter-based cerebral protection system: transferring percutaneous technologies into a surgical intervention. Eur J Cardiothorac Surg. 2019. PMID: 31056703. doi:10.1093/ejcts/ezz126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。